MICAH TROUP: Open Payments
NPI 1871202291 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,067 in 86 payments from 15 companies in 2025. Trend: 2023 $316 · 2024 $2,256 · 2025 $2,067
Food & beverage: $2,021Education: $45
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 25 | $595 |
| Novartis Pharmaceuticals Corporation | 12 | $334 |
| Otsuka America Pharmaceutical, Inc. | 12 | $289 |
| Ardelyx, Inc. | 8 | $192 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $96 |
| Travere Therapeutics, Inc. | 4 | $96 |
| Alexion Pharmaceuticals, Inc. | 3 | $85 |
| Novo Nordisk Inc | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Calliditas Therapeutics US Inc. | 3 | $68 |
Products named: Kerendia, JYNARQUE, IBSRELA, Vanrafia, Fabhalta, ULTOMIRIS, Wegovy, JARDIANCE.
Industry payments across MI — which companies pay providers there.
